Here’s what you should know:
1. Researchers enrolled 47 cases at three sites in Europe. The Pure-Vu system was used in subjects with partially prepared colons who took two 10 mg Bisacodyls and had diet restrictions before the procedure.
2. The Pure-Vu system significantly increased the number of subjects with an “adequate” cleansing level for all three colon segments. After using the Pure-Vu system, physicians reached and visualized the cecum in 46 of 47 cases.
3. Pure-Vu CEO Tim Moran said, “We are pleased to have the data from our European clinical feasibility study selected for publication in this prestigious, peer-reviewed journal. The data bolsters our confidence in the Pure-Vu System’s ability to successfully cleanse the colon to a high level regardless of the adequacy of the pre-procedural prep.”
More articles on gastroenterology:
Healthcare supply chain management market to grow 8% — 4 takeaways
ASC supply chain tip of the day: Find product alternatives
3 New Years’ resolutions for your surgery center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.